Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
December 29, 2011
In Re: Actos (Pioglitazone) Products Liability Litigation
Case Number:
6:11-md-02299
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Adams & Reese
- Aylstock Witkin
- Baker Sterchi
- Beasley Allen
- Campbell Conroy
- Carlton Fields
- Cline Williams
- Davidson Meaux
- Douglas & London
- Drakulich Firm
- Faegre Drinker
- Foliart Huff
- Fox Smith
- Fulmer Sill
- Gallivan White
- Goodell DeVries
- Greenberg Traurig
- Huie Fernambucq
- Ice Miller
- Jones Walker
- Lanier Law Firm
- Levin Papantonio
- Lewis Roca
- Lieff Cabraser
- Maron Marvel
- McGlinchey Stafford
- McGowan Hood
- Mitchell Williams
- Montgomery McCracken
- Morrow Morrow
- Neblett Beard
- Nelson Mullins
- Norton Rose
- Orrick Herrington
- Parker Waichman
- Reed Smith
- Robinson Calcagnie
- Seeger Weiss
- Shook Hardy
- Sidley Austin
- Simmons Hanly
- Spilman Thomas
- Squire Patton
- Stites & Harbison
- Tucker Ellis
- Venable LLP
- Wagstaff Law Firm
- Wyrick Robbins
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 14, 2015
Takeda Says Most Actos Claimants Want In On $2.4B Deal
Takeda Pharmaceutical Company Ltd. said Friday that more than 96 percent of claimants have sought a share of the Japanese drugmaker's proposed deal of up to $2.4 billion to resolve claims that it hid the alleged bladder cancer risks of its diabetes drug Actos.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login